Cargando…

Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates

BACKGROUND: Expanding resistance to multiple antimalarials, including chloroquine, in South-East Asia (SEA) urges the development of new therapies. AQ-13, a chloroquine derivative, is a new drug candidate for treating malaria caused by Plasmodium falciparum. OBJECTIVES: Possible cross-resistance bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nardella, Flore, Mairet-Khedim, Mélissa, Roesch, Camille, Maher, Steven P, Ke, Sopheakvatey, Leang, Rithea, Leroy, Didier, Witkowski, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446910/ https://www.ncbi.nlm.nih.gov/pubmed/34245274 http://dx.doi.org/10.1093/jac/dkab219

Ejemplares similares

Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia
por: Mairet-Khedim, Melissa, et al.
Publicado: (2020)

Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia
por: Mairet-Khedim, Mélissa, et al.
Publicado: (2022)

G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients
por: Khim, Nimol, et al.
Publicado: (2013)

Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia
por: Roesch, Camille, et al.
Publicado: (2020)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
por: Tekete, Mamadou, et al.
Publicado: (2009)

Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine
por: Warhurst, David C
Publicado: (2003)

Artesunate Plus Amodiaquine (AS+AQ) Versus Artemether -Lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Sub-Saharan Africa-A Meta-Analysis
por: Bello, Shaibu O, et al.
Publicado: (2010)

Amodiaquine failure associated with erythrocytic glutathione in Plasmodium falciparum malaria
por: Zuluaga, Lina, et al.
Publicado: (2007)

Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei
por: Badejo, Joseph A, et al.
Publicado: (2014)

Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa)
por: Charle, Pilar, et al.
Publicado: (2009)

Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon
por: Moyeh, Marcel N., et al.
Publicado: (2018)

Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
por: Duru, Valentine, et al.
Publicado: (2015)

On the Mechanism of Chloroquine Resistance in Plasmodium falciparum
por: Chinappi, Mauro, et al.
Publicado: (2010)

Chloroquine-resistant Plasmodium falciparum in Pakistan
por: Khattak, Aamer Ali, et al.
Publicado: (2021)

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study
por: Witkowski, Benoit, et al.
Publicado: (2017)

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
por: Venkatesan, Meera, et al.
Publicado: (2014)

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India
por: Anvikar, Anupkumar R, et al.
Publicado: (2012)

Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites
por: Lee, Andrew H., et al.
Publicado: (2016)

Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia
por: Mekonnen, Seleshi Kebede, et al.
Publicado: (2014)

DNA Methylation Bisubstrate Inhibitors Are Fast-Acting Drugs Active against Artemisinin-Resistant Plasmodium falciparum Parasites
por: Nardella, Flore, et al.
Publicado: (2019)

Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018
por: Dentinger, Catherine M., et al.
Publicado: (2021)

Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization
por: Boonyalai, Nonlawat, et al.
Publicado: (2020)

Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia
por: Leang, Rithea, et al.
Publicado: (2013)

Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
por: Bopp, Selina, et al.
Publicado: (2018)

Chloroquine-Resistant Haplotype Plasmodium falciparum Parasites, Haiti
por: Londono, Berlin L., et al.
Publicado: (2009)

The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia
por: Mwanza, Sydney, et al.
Publicado: (2016)

Introducing New Antimalarial Analogues of Chloroquine and Amodiaquine: A Narrative Review
por: Parhizgar, Arezoo Rafiee, et al.
Publicado: (2017)

Complexity of Infection and Genetic Diversity in Cambodian Plasmodium vivax
por: Friedrich, Lindsey R., et al.
Publicado: (2016)

Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine
por: Sowunmi, Akintunde, et al.
Publicado: (2008)

In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014
por: Paczkowski, Magdalena, et al.
Publicado: (2016)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
por: Raobela, Oméga, et al.
Publicado: (2018)

Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community
por: Auerswald, Heidi, et al.
Publicado: (2018)

Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach
por: Canavati, Sara E., et al.
Publicado: (2016)

Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes
por: Wirjanata, Grennady, et al.
Publicado: (2017)

Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies
por: Tripura, Rupam, et al.
Publicado: (2016)

Structural and evolutionary analyses of the Plasmodium falciparum chloroquine resistance transporter
por: Coppée, Romain, et al.
Publicado: (2020)

Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy
por: Jeong, Hye Yun, et al.
Publicado: (2018)

In vivo efficacy and safety of artemether–lumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018
por: Nhama, Abel, et al.
Publicado: (2021)

Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea
por: Riloha Rivas, Matilde, et al.
Publicado: (2021)

The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008–2011
por: Eyase, Fredrick L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o57r23kj0o8g11b7t79mm766i4